Management Team

Meet our Leadership Team.

Together, they are furthering InfoBionic’s mission: to redefine the standard of care for patients and physicians alike with our full disclosure remote cardiac arrhythmia monitoring platform.

Stuart Long Stuart Longlinkedin
Chief Executive Officer

Stuart was appointed CEO of InfoBionic in March 2017, underscoring the Company’s commitment to widespread market adoption of its transformative wireless remote patient monitoring platform for chronic disease management. With more than 20 years of experience in the medical device market, Stuart brings a great deal of expertise in achieving rapid commercial growth. Prior to joining InfoBionic, he was CEO at Monarch Medical Systems, LLC, a Charlotte-based, artificial intelligence clinical decision support software provider for insulin dosing calculations, where he oversaw the organizational restructuring of the company.

Prior to Monarch, Stuart served as the global chief marketing and sales officer for CapsuleTech, Inc., a medical device integration and clinical data management system for hospitals and healthcare institutions. During his tenure, he developed and executed a strategic business and product plan that ultimately led to the company’s acquisition by Qualcomm Life, Inc., a subsidiary of Qualcomm, Inc. Prior to CapsuleTech, Stuart worked in executive leadership at Philips Healthcare, overseeing global product management and marketing for their healthcare imaging and informatics group as well as emerging markets in the company’s cardiac monitoring division. Stuart also held executive positions at healthcare IT-focused companies including Agfa Healthcare, AMICAS, FUJIFILM USA and Eastman Kodak in addition to his previous clinical experience of managing acute care, non-invasive cardiology.

Michael AnselmoMichael Anselmolinkedin
Vice President, Healthcare Economics and Reimbursement

Michael joined InfoBionic in February 2018 with a mandate to help healthcare providers realize the advantages of true technical and global reimbursement for their ambulatory cardiac monitoring service lines. Prior to joining InfoBionic, Michael has had key roles with United Healthcare, Abbott/St. Jude Medical and several consulting firms where he provided numerous solutions for his clients and customers based on market insights and data analytics. His specialties include Health Policy, Economic Modeling and Strategic Analysis.

Eric BaumannEric Baumannlinkedin
Chief Technology Officer

Eric has worked in diagnostic ambulatory electrocardiography for over 30 years. He has successfully led product teams introducing many of the firsts in the AECG space including automatic AF detection, mobile telemetry, AF burden and full disclosure. Eric earned his bachelor of science in computer science and is a graduate of the product development program at Harvard Business School.

Karen JimenezKaren Jimenezlinkedin
Senior Director of Marketing


Dave MacCutheonDave MacCutcheonlinkedin
Chief Operating Officer

Dave is tenured in the healthcare industry and has been at the leading edge of the digital revolution, launching influential and innovative products in the marketplace and actively developing new ones. Prior to joining InfoBionic, Dave was Vice President of Product Management at TeraRecon, Inc., which incorporates AI and world-class image processing tools into the next-generation of medical image viewing, interpretation, sharing and collaboration solutions. He was also previously VP of Product Management at Monarch Medical Technologies where he led the design, development and delivery of one of the newest solutions in intravenous and subcutaneous insulin dosing software, analytics, HL7 and EMR integrations.

Paul McEwanPaul McEwanlinkedin
Chief Financial Officer

Paul brings to InfoBionic more than 25 years of financial experience, predominantly in the Life Sciences Industry. Paul is responsible for all aspects of InfoBionic’s financial strategy. Prior to joining InfoBionic Paul served as Chief Financial Officer of SeraCare Life Sciences, Inc., a company partnering with IVD manufacturers and clinical laboratories to bridge the gap between today’s diagnostic solutions and tomorrow’s emerging technologies for molecular diagnostics, next generation sequencing and companion diagnostics. SeraCare was sold to LGC, a portfolio company of KKR in November 2018. Prior to SeraCare Paul was Chief Financial Officer of Microline Surgical, Inc., a company developing and manufacturing high precision open and laparoscopic surgical instruments.

Prior to Microline Surgical, he served as Vice President and Chief Financial Officer of NeuroTherm, Inc., a medical device company that develops, manufactures, and markets state-of-the-art image-guided solutions for pain management. In this role he was instrumental in the divestiture of NeuroTherm to St Jude Medical in August 2014. Paul joined NeuroTherm after spending 11 years with Optos, a medical technology company specializing in devices that image the retina, where he was Director of Finance and then Vice President of Financial Planning and Analysis. Paul earned a Masters of Business Administration from the Edinburgh Business School, University of Herriot Watt (Edinburgh, United Kingdom), and a HNC in Accounting from Dundee University (Dundee, United Kingdom). He is a member of the Chartered Institute of Management Accountants in the UK and the Institute of Management Accountants in the USA.